Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy

被引：0

作者：

Rajeh, Ahmad ^{[1
]}

Ferree, Sarah ^{[1
]}

Anadkat, Milan J. ^{[1
]}

机构：

[1] Washington Univ, Div Oncol, Sch Med, 660 S Euclid Ave,Campus Box 8123, St Louis, MO 63110 USA

来源：

JAMA DERMATOLOGY | 2024年 / 160卷 / 05期

关键词：

D O I：

10.1001/jamadermatol.2024.0124

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This case report describes a woman in her 70s with a history of breast cancer and chronic lymphocytic leukemia who presented with a painful rash of the bilateral chest extending onto the flanks.

引用

页码：577 / 578

页数：2

共 50 条

[1] Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy
Taneja, Alankrita
Jones, Jade
Pittaluga, Stefania
Maric, Irina
Farooqui, Mohammed
Ahn, Inhye E.
Wiestner, Adrian
Sun, Clare
LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 519 - 522
[2] Novel Hemorrhagic Dermatologic Toxicity Associated with Bruton's Tyrosine Kinase Inhibitor Therapy
Schmidt, Nicholas J., Jr.
Isaac, Krista
Williams, Michael E.
Flowers, Richard
Zufall, Alina
Patel, Krishna
BLOOD, 2021, 138
[3] Scedosporium Brain Abscess: A Rare and Fatal Drawback of Bruton Tyrosine Kinase Inhibitor Therapy
Dalmazzo, Matteo
Padrini, Melissa
Camerlo, Sofia
Rosati, Giorgio
Busana, Tiziano Tommaso
Nicoli, Paolo
Perotto, Fabio
Davicco, Luca
Caironi, Pietro
De Gobbi, Marco
Morotti, Alessandro
JOURNAL OF HEMATOLOGY, 2024, 13 (05) : 224 - 228
[4] Ocular Surface Squamous Neoplasia In Situ Secondary to Bruton Tyrosine Kinase Inhibitor Therapy
Bloomquist, Ryan F.
Sakhalkar, Monali V.
Fowler, Teresa E.
Bloomquist, Doan T.
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2024, 50 (11): : 498 - 499
[5] Bruton tyrosine kinase
不详
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (03) : 181 - 181
[6] Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Woyach, Jennifer A.
Furman, Richard R.
Liu, Ta-Ming
Ozer, Hatice Gulcin
Zapatka, Marc
Ruppert, Amy S.
Xue, Ling
Li, Daniel Hsieh-Hsin
Steggerda, Susanne M.
Versele, Matthias
Dave, Sandeep S.
Zhang, Jenny
Yilmaz, Ayse Selen
Jaglowski, Samantha M.
Blum, Kristie A.
Lozanski, Arletta
Lozanski, Gerard
James, Danelle F.
Barrientos, Jacqueline C.
Lichter, Peter
Stilgenbauer, Stephan
Buggy, Joseph J.
Chang, Betty Y.
Johnson, Amy J.
Byrd, John C.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2286 - 2294
[7] Novel leflunomide analog inhibitor of Bruton's tyrosine kinase
Mahajan, S
Ghosh, S
Sudbeck, E
Zheng, YG
Downs, S
Uckun, FM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U283 - U283
[8] Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)
Burger, Jan A.
Buggy, Joseph J.
LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2385 - 2391
[9] The first oral Bruton Tyrosine Kinase Inhibitor for the Treatment of CLL
不详
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (12) : 707 - 707
[10] Bruton Tyrosine Kinase Inhibitor in 2 Patients With Vitreoretinal Lymphoma
Iwahashi, Chiharu
Sakamoto, Masuo
Ohguro, Nobuyuki
Kusaka, Shunji
JAMA OPHTHALMOLOGY, 2023, 141 (11) : 1085 - 1088

← 1 2 3 4 5 →